# A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure

> **NCT07218627** · PHASE1 · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 36 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** NNC0537-1482
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07218627
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-23
- **Primary completion:** 2027-01-15
- **Final completion:** 2027-01-15
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07218627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07218627, "A Research Study on the Effects of NNC0537-1482 in Participants With Heart Failure". Retrieved via AI Analytics 2026-07-21 from https://api.ai-analytics.org/clinical/NCT07218627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*